Many anesthetics, including the volatile agent halothane, prolong the decay of GABA A receptor-mediated IPSCs at central synapses. This effect is thought to be a major factor in the production of anesthesia. A variety of different kinetic mechanisms have been proposed for several intravenous agents, but for volatile agents the kinetic mechanisms underlying this change remain unknown. To address this question, we used rapid solution exchange techniques to apply GABA to recombinant GABA A receptors (␣ 1  2 ␥ 2s ) expressed in HEK 293 cells, in the absence and presence of halothane. To differentiate between different microscopic kinetic steps that may be altered by the anesthetic, we studied a variety of measures, including peak concentration-response characteristics, macroscopic desensitization, recovery from desensitization, maximal current activation rates, and responses to the low-affinity agonist taurine. Experimentally observed alterations were compared with predictions based on a kinetic scheme that incorporated two agonist binding steps, and open and desensitized states. We found that, in addition to slowing deactivation after a brief pulse of GABA, halothane increased agonist sensitivity and slowed recovery from desensitization but did not alter macroscopic desensitization or maximal activation rate and only slightly slowed rapid deactivation after taurine application. This pattern of responses was found to be consistent with a reduction in the microscopic agonist unbinding rate (k off ) but not with changes in channel gating steps, such as the channel opening rate (), closing rate (␣), or microscopic desensitization. We conclude that halothane slows IPSC decay by slowing dissociation of agonist from the receptor.
Key words: GABA; halothane; taurine; synaptic inhibition; anesthetics; receptor kineticsThe activity of ligand-gated ion channels can be described in kinetic terms by defining transition rates between individual metastable states of the receptor. Drug action can then be viewed as altering the transition rates between these states, under the assumption that drug binding does not introduce new transitions to the kinetic scheme. Using this approach to study pharmacological modulation of the GABA A receptor, it has been proposed that barbiturates alter transition rates between agonist-bound closed states (Macdonald et al., 1989a;Macdonald and Olsen, 1994), neurosteroids decrease the exit rate from the desensitized state of the receptor (Zhu and Vicini, 1997), and benzodiazepines increase the agonist binding rate (Rogers et al., 1994) or decrease agonist unbinding rate and accelerate desensitization (Mellor and Randall, 1997). In addition, it has been proposed that dephosphorylation of the GABA A receptor reduces the agonist unbinding rate, slowing deactivation and prolonging inhibitory currents (Jones and Westbrook, 1997).The volatile anesthetic halothane prolongs GABA A receptormediated IPSCs (Gage and Robertson, 1985;Mody et al., 1991;Jones and Harrison, 1993;Pearce, 1996), as do a great number o...